United News of Bangladesh

Sierra Leone has declared the end of an mpox outbreak in the country. The declaration on Tuesday aligns with international health standards, which require a minimum of 42 days without a new confirmed case, Health Minister Austin Demby told a ceremony marking the second anniversary of the National Public Health Agency (NPHA). All 16 districts with reported cases have exceeded the 42-day timeframe, with several areas surpassing 150 days since their last infection. Since the first mpox case was recorded on Jan. 9, Sierra Leone has reported 5,442 confirmed cases, including 60 deaths. Foday Sahr, executive director of the NPHA, said the agency's establishment symbolizes Sierra Leone's commitment to never again facing health emergencies unprepared. The ceremony drew commendations from global health leaders, including Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, and Jean Kaseya, director-general of the Africa Centers for Disease Control and Prevention, who praised Sierra Leone's efforts in effectively addressing public health threats.  

UN Human Rights Chief Volker Türk on Tuesday said he was appalled by the escalating violence in Nepal that has resulted in multiple deaths and the injury of hundreds of mostly young protesters, as well as the widespread destruction of property. “I plead with security forces to exercise utmost restraint, and avoid further such bloodshed and harm,” he said, adding that violence is not the answer. “Dialogue is the best and only way to address the concerns of the Nepalese people. It is important that the voices of young people are heard.” The High Commissioner said protesters have the right to express peacefully their political frustrations and grievances over corruption and a ban on social media platforms. “I have received concerning reports of unnecessary and disproportionate use of force by the security forces,” said Türk. “I call for urgent, thorough, transparent and impartial investigation into such acts.” Ex-Nepal PM’s wife dies after protestets set their home on fire He reminded protesters that they too must uphold the spirit of peaceful assembly and refrain from violence. “I am disturbed by reports of public buildings, businesses and private residences being attacked and, in some instances, set ablaze. Equally, I am concerned by reports of physical attacks on senior government officials.” The world has admired Nepal’s emergence from conflict to become a peaceful democracy, Türk said, appealing to all Nepalese stakeholders to find a way forward to continue on that path. “Together with the United Nations system, my Office stands ready to support dialogue and trust-building measures that can help de-escalate tensions and restore confidence,” the High Commissioner said.

In what could prove to be a major breakthrough for cancer patients, an mRNA-based vaccine has been developed, demonstrating 100% efficacy and safety in clinical trials. The Enteromix vaccine showed promising results during trials, helping patients with large tumors by significantly reducing their size and effectively destroying cancer cells, reports WION. According to Russia Today (RT), the vaccine is now only awaiting final approval from the Russian Ministry of Health for public rollout. Developed in Russia, Enteromix is the first cancer vaccine to utilize the same mRNA technology platform that was successfully used in COVID-19 vaccines. This next-generation immunotherapy is designed to precisely target and eliminate cancer cells, offering new hope to millions of cancer patients worldwide. Enteromix is administered via intramuscular injection and has already been introduced for early clinical use in several oncology centers across Russia. Unlike traditional treatments like chemotherapy or radiation, Enteromix follows a personalized approach, tailoring the therapy to each individual patient. Notably, no serious side effects were reported during clinical trials. The vaccine was developed by the Russian Ministry of Health’s National Medical Research Radiological Centre, in collaboration with the Engelhardt Institute of Molecular Biology (EIMB) of the Russian Academy of Sciences (RAS). Who can benefit from Enteromix? Patients suffering from lung, breast, colorectal, or pancreatic cancers can benefit from the vaccine. It may also be effective for high-risk individuals with hereditary cancer syndromes (e.g., BRCA1/2) and those whose cancers are resistant to chemotherapy. Additionally, immunocompromised patients who cannot tolerate conventional treatments may look to Enteromix as a safer alternative. Following its successful clinical trials, the vaccine now only awaits regulatory clearance from the Russian government.

Global efforts to vaccinate children against preventable diseases have stalled since 2010, leaving millions at risk for illnesses such as tetanus, polio, tuberculosis, and measles, according to a new study published Tuesday in The Lancet. The analysis, conducted by researchers at the Institute for Health Metrics and Evaluation at the University of Washington, reveals a significant decline in vaccination rates—particularly after the COVID-19 pandemic, as reported by AP. The report warns that protection from measles dropped in 100 countries between 2010 and 2019, unraveling decades of progress. This includes setbacks in high-income countries that had previously eradicated the disease. “After clean water, vaccination is the most effective intervention for protecting the health of our children,” said Helen Bedford, a professor of children's health at University College London, who was not connected to the research. She added that recent years have seen “a small but worrying rise in the number of parents skipping vaccination for their children,” citing misinformation as one of the contributing factors. In the UK, this trend has led to the largest number of measles cases since the 1990s and nearly a dozen deaths from whooping cough. The United States is also experiencing a drop in vaccination rates, with exemption levels hitting an all-time high. The global immunization initiative, launched by the World Health Organization (WHO) in 1974, was credited with inoculating over 4 billion children and saving an estimated 154 million lives. Philippine village offers bounties for mosquitoes-dead or alive Before the pandemic, the coverage of children receiving three doses of the diphtheria-tetanus-whooping cough vaccine had nearly doubled from 40% to 81%. Measles vaccination rates increased from 37% to 83%, with similar progress for polio and tuberculosis. However, the COVID-19 pandemic disrupted these gains. An estimated 15.6 million children missed doses of both the diphtheria-tetanus-whooping cough vaccine and the measles vaccine. Approximately 16 million children missed the polio vaccine, and 9 million did not receive the TB vaccine—most notably in sub-Saharan Africa. The study was funded by the Bill & Melinda Gates Foundation and Gavi, The Vaccine Alliance. Researchers also identified that over half of the world’s 15.7 million unvaccinated children in 2023 lived in just eight countries: Nigeria, India, Congo, Ethiopia, Somalia, Sudan, Indonesia, and Brazil. Experts have voiced concern that political decisions may further hamper immunization efforts. Since former President Donald Trump initiated the withdrawal of the U.S. from the WHO and began dismantling the U.S. Agency for International Development, public health authorities have warned of an increased risk of infectious disease outbreaks. However, the researchers cautioned that it is too early to determine the exact impact of recent funding cuts on global vaccination rates. The WHO has reported alarming increases in measles cases. In the Americas, there has been an 11-fold surge in infections this year compared to 2024. In Europe, measles cases doubled in 2024, while the disease remains prevalent in Africa and Southeast Asia. “It is in everyone's interest that this situation is rectified,” said Dr. David Elliman, a pediatrician who has advised the British government. “While vaccine-preventable infectious diseases occur anywhere in the world, we are all at risk.”

Sinovac, a leading global biopharmaceutical company, hosted its "Sinovac Open Day for International Media" event on Friday, welcoming journalists from around 30 countries. The event provided an in-depth look at Sinovac’s operations and ongoing global initiatives aimed at advancing public health. The programme began with a welcome speech from Pearson Liu, Senior Assistant to the Chief Business Officer of Sinovac Holding Group Co., Ltd. In his address, Liu highlighted the company’s commitment to innovation, global partnerships, and the development of life-saving vaccines. He emphasised Sinovac’s role in combating global health challenges, underscoring its dedication to improving health outcomes worldwide. Ying Zhang, Deputy General Manager of Sinovac Life Science Co., Ltd., also spoke at the event, offering insights into the company’s research and development strategies, particularly focusing on vaccine production and distribution. Zhang outlined the company’s international collaborations and its mission to provide accessible, effective healthcare solutions globally. Replying to a question about the quality and safety of vaccines delivered to countries like Bangladesh during the COVID-19 pandemic, Perry Peng, Country Business Development Manager of Sinovac's International Department, said Sinovac ensures the highest standards of quality and safety for every country it serves.

Thirty years after world leaders adopted a historic blueprint to achieve gender equality, a new United Nations report says women’s and girls’ rights are under attack and gender discrimination remains deeply embedded in economies and societies. The report released Thursday by the U.N. agency focused on women’s rights and gender equality found that nearly one-quarter of governments worldwide reported a backlash to women’s rights last year. Despite some progress, including on girls’ education and access to family planning, UN Women said a woman or girl is killed every 10 minutes by a partner or family member and that cases of conflict-related sexual violence have increased by 50% since 2022. The report, released ahead of International Women’s Day on Saturday, also noted that only 87 countries have ever been led by a woman. “Globally, women’s human rights are under attack,” U.N. Secretary-General Antonio Guterres said in a statement. “Instead of mainstreaming equal rights, we’re seeing the mainstreaming of misogyny.” He said the world must stand firm “in making human rights, equality and empowerment a reality for all women and girls, for everyone, everywhere.” The 189 countries that attended a 1995 Beijing women’s conference adopted a landmark declaration and 150-page platform for action to achieve gender equality, calling for bold action in 12 areas, including combating poverty and gender-based violence and putting women at top levels in business, government and at peacemaking tables. It also said for the first time in a U.N. document that human rights include the right of women to control and decide “on matters relating to their sexuality, including their sexual and reproductive health, free of discrimination, coercion and violence.” In the new review, which includes contributions from 159 countries, UN Women said countries have taken many steps forward on gender equality and women’s rights in the past five years but that such rights still are facing growing threats worldwide. On the positive side, the report said some 88% of countries have passed laws to combat violence against women and established services to help victims in the past five years. Most countries have banned workplace discrimination, and 44% are improving the quality of education and training for girls and women, it said. Overturning of Roe v Wade abortion law huge blow to women's rights: Bachelet Yet gender discrimination is deeply embedded, with wide gaps in power and resources that restrain women’s rights, the report said. “The weakening of democratic institutions has gone hand in hand with backlash on gender equality,” UN Women said. It warned that “anti-rights actors are actively undermining longstanding consensus on key women’s rights issues” and seeking to block or slow legal and policy gains they can’t roll back. UN Women said almost 25% of countries reported that backlash on gender equality is hampering implementation of the Beijing platform. According to the report, women have only 64% of the legal rights of men, and while the proportion of female lawmakers has more than doubled since 1995, three-quarters of lawmakers are still men. UN Women also said women aged 15 to 24 lag behind other age groups on access to modern family planning; maternal mortality ratios have remained almost unchanged since 2015; and 10% of women and girls live in extremely poor households. The U.N. agency said cases of conflict-related sexual violence have increased 50% since 2022 — and women and girls are victims of 95% of these crimes. UN Women Executive Director Sima Bahous said that based on the report’s findings, the agency has adopted a roadmap to bring the world closer to the U.N. goal of achieving gender equality by 2030. Pakistan reaffirms commitment for protection, promotion of women's rights It calls for a digital revolution ensuring equal access to technology for all women and girls; investments in social protections, including universal health care and quality education to lift them out of poverty; and zero violence against girls and women. The roadmap also includes equal decision-making power for women and financing for “gender-responsive humanitarian aid” in conflicts and crises.

The U.N. human rights chief has expressed concern about a “fundamental shift in direction” taking place in the United States when it comes to human rights. Volker Türk, the U.N. high commissioner for human rights, also praised bipartisan support for human rights for decades and the “generosity and compassion” of the American people in a sweeping address on his concerns on dozens of issues and country situations, including China, India, Russia, the United States and beyond. He expressed new concerns about a change in tack in Washington. “I am now deeply worried by the fundamental shift in direction that is taking place domestically and internationally,” the rights chief told the Human Rights Council. “Divisive rhetoric is being used to distort, deceive and polarize. This is generating fear and anxiety among many.” Türk did not specifically refer to the Trump administration, which announced pulling the United States out of the 47-member-country council in January — even though the Biden administration had already said last year that the U.S. would not seek a new three-year term. A seat reserved for a U.S. representative sat empty on Monday, the start of the Week 2 of the council's 5-1/2 week session. The rights body holds three sessions a year. Alluding to the United States, Türk lamented how policies aimed to protect people from discrimination “are now labeled as discriminatory,” and said intimidation and threats “notably against journalists and public officials” risk undermining the work of institutions and independent media. The rights chief also issued a stark warning about the threat from unchecked use and development of technology. He mentioned the power of “a handful of unelected tech oligarchs” and insisted it’s time to adapt fast to the threat of rising oppression and autocratic rule. UN Human Rights Office to launch OHCHR fact-finding report on July movement “Individuals and corporations have never had so much control and influence over our lives," Türk said. "A handful of unelected tech oligarchs have our data: they know where we live, what we do, our genes and our health conditions, our thoughts, our habits, our desires and our fears. They know us better than we know ourselves. And they know how to manipulate us.” “Any form of unregulated power can lead to oppression, subjugation, and even tyranny – the playbook of the autocrat,” Türk said. “We must adapt – fast.”

Chinese researchers have identified a new therapeutic target for Parkinson’s disease, a neurodegenerative disorder with high disability and mortality rates, and have successfully discovered a promising small-molecule drug. A research team from Huashan Hospital, affiliated with Fudan University in Shanghai, achieved this breakthrough, which could enable early intervention in Parkinson’s disease and offer hope for slowing its progression. The findings were published on Friday (Beijing time) in the renowned academic journal Science. Parkinson’s disease, the second most common neurodegenerative disorder after Alzheimer’s, affects around 3 million people in China—roughly half of the global total. Patients often first experience a diminished sense of smell and sleep disturbances before developing more severe movement-related symptoms. As the disease advances, the effectiveness of existing medications decreases, significantly impacting patients' quality of life. While current drugs and surgical treatments mainly alleviate symptoms without halting disease progression, further research into its underlying mechanisms and targeted therapies remains essential, scientists say. Following five years of dedicated research, the team identified FAM171A2 as a crucial risk gene for neurodegeneration. Leveraging artificial intelligence, they screened over 7,000 approved compounds and identified bemcentinib, an anti-cancer agent currently in clinical trials, as a promising candidate. HMPV virus: Passengers asked to wear masks at Dhaka airport According to the researchers, the small-molecule drug effectively prevents the interaction between FAM171A2 and the pathogenic protein associated with Parkinson’s. Team leader Yu Jintai stated that, based on an international patent, future efforts will focus on pre-clinical research and the development of small-molecule drugs, antibodies, and gene therapies for Parkinson’s disease, with the goal of advancing clinical trials and innovative treatments. The elderly, particularly those over 60, are more susceptible to Parkinson’s. As China’s population continues to age, this medical breakthrough has generated optimism among academics, medical professionals, and patients, with expectations that it will lead to practical applications soon. "The experimental results have allowed us to precisely understand the pathophysiological mechanisms of Parkinson’s disease, bringing us closer to overcoming a challenge long considered insurmountable," said Wang Jian, director of the neurology department at Huashan Hospital, a national medical center for neurological diseases. A Science journal reviewer described the discovery as a “holy grail” in Parkinson’s research, emphasizing its potential to prevent the spread of pathological changes and, ultimately, the disease itself. As neurological diseases like Parkinson’s and Alzheimer’s pose growing global public health and social challenges, Chinese experts are urging increased efforts in brain science research. They highlight the need for improved diagnostic tools, early intervention strategies, and novel treatments to enhance patients' quality of life.

A village in Mandaluyong City, part of the Philippine capital region, initiated a novel approach to combat dengue on Wednesday by offering residents small rewards for capturing mosquitoes—alive or dead. This initiative, adopted by Addition Hills village, comes in response to growing concern after Quezon City, nearby, declared a dengue outbreak over the weekend. Cases of the mosquito-borne disease have surged, with eight other areas also reporting increased infections. As of February 1, the Philippines has recorded 28,234 dengue cases this year, marking a 40% rise compared to the same period last year. Quezon City declared an outbreak after 10 deaths, mostly children, among 1,769 infected individuals. Addition Hills, a densely populated urban area with over 100,000 residents, has already conducted clean-ups, canal de-clogging, and hygiene awareness campaigns to combat dengue. However, after the number of cases spiked to 42 this year, and two young students died, village leader Carlito Cernal decided to ramp up efforts. “There was an alarm,” Cernal told The Associated Press. “I found a way." Under the new plan, residents receive one Philippine peso (about 1 cent) for every five mosquitoes or larvae they turn in. While some critics have raised concerns that people may breed mosquitoes for rewards, Cernal dismissed this possibility, noting that the campaign would end once the number of cases decreases. As the initiative began, several mosquito hunters showed up at the village office. Miguel Labag, a 64-year-old scavenger, brought a jug containing 45 mosquito larvae and received a reward of nine pesos (15 cents). “This is a big help,” Labag said, smiling. “I can buy coffee.” Dengue is a viral infection transmitted by mosquitoes, causing symptoms like joint pain, nausea, and rashes. In severe cases, it can lead to breathing issues, hemorrhaging, and organ failure. While there is no specific treatment, maintaining fluid levels is critical for recovery. In Quezon City, officials are considering using frogs to combat mosquitoes, while Health Secretary Teodoro Herbosa emphasized the importance of eliminating mosquito breeding sites and seeking immediate medical attention for suspected cases. Despite a rise in dengue infections, the Philippines has managed to maintain relatively low mortality rates. Dengue cases have surged unexpectedly before the rainy season, with intermittent rain leaving stagnant water pools that are ideal breeding grounds for mosquitoes. Health Undersecretary Alberto Domingo also cited climate change as a factor contributing to off-season rainfall.

Sierra Leone has declared a state of emergency after confirming a second case of mpox within four days, health officials announced on Monday, reports AP. According to the health ministry, neither of the cases had any recent contact with infected animals or individuals. The first case was linked to recent travel, confined to Lungi, an airport town in the northern Port Loko District, between December 26 and January 6. Both patients are being treated in a hospital in Freetown, the capital. Morocco develops Africa's first Mpox tests, reducing reliance on imports Mpox, also called monkeypox, was first identified in 1958 during outbreaks of a “pox-like” disease among monkeys. Historically, most human cases occurred in central and West Africa, typically among people in close contact with infected animals. In 2022, mpox was confirmed to spread via sexual transmission for the first time, leading to outbreaks in over 70 countries that had not previously reported the virus. The Congo has been the hardest hit, accounting for most of the estimated 43,000 suspected cases and 1,000 deaths in Africa this year. US health officials report 1st case of new strain of mpox in a traveler Sierra Leone was also at the heart of the 2014 Ebola outbreak, the deadliest in history. The outbreak, which mainly affected West Africa, claimed nearly 4,000 lives in Sierra Leone alone, out of a global total of over 11,000. The country lost 7% of its healthcare workforce during that crisis.